These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35660215)

  • 21. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study.
    Banerjee A; Pasea L; Harris S; Gonzalez-Izquierdo A; Torralbo A; Shallcross L; Noursadeghi M; Pillay D; Sebire N; Holmes C; Pagel C; Wong WK; Langenberg C; Williams B; Denaxas S; Hemingway H
    Lancet; 2020 May; 395(10238):1715-1725. PubMed ID: 32405103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Premature mortality projections in the USA through 2030: a modelling study.
    Best AF; Haozous EA; Berrington de Gonzalez A; Chernyavskiy P; Freedman ND; Hartge P; Thomas D; Rosenberg PS; Shiels MS
    Lancet Public Health; 2018 Aug; 3(8):e374-e384. PubMed ID: 30037721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study.
    Krishnamurthi RV; Moran AE; Feigin VL; Barker-Collo S; Norrving B; Mensah GA; Taylor S; Naghavi M; Forouzanfar MH; Nguyen G; Johnson CO; Vos T; Murray CJ; Roth GA;
    Neuroepidemiology; 2015; 45(3):190-202. PubMed ID: 26505983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.
    Foreman KJ; Marquez N; Dolgert A; Fukutaki K; Fullman N; McGaughey M; Pletcher MA; Smith AE; Tang K; Yuan CW; Brown JC; Friedman J; He J; Heuton KR; Holmberg M; Patel DJ; Reidy P; Carter A; Cercy K; Chapin A; Douwes-Schultz D; Frank T; Goettsch F; Liu PY; Nandakumar V; Reitsma MB; Reuter V; Sadat N; Sorensen RJD; Srinivasan V; Updike RL; York H; Lopez AD; Lozano R; Lim SS; Mokdad AH; Vollset SE; Murray CJL
    Lancet; 2018 Nov; 392(10159):2052-2090. PubMed ID: 30340847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.
    Degeling K; Baxter NN; Emery J; Jenkins MA; Franchini F; Gibbs P; Mann GB; McArthur G; Solomon BJ; IJzerman MJ
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):359-367. PubMed ID: 33567163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK.
    Gheorghe A; Maringe C; Spice J; Purushotham A; Chalkidou K; Rachet B; Sullivan R; Aggarwal A
    Eur J Cancer; 2021 Jul; 152():233-242. PubMed ID: 34049776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Mental Disorders Collaborators
    Lancet Psychiatry; 2022 Feb; 9(2):137-150. PubMed ID: 35026139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, prevalence, mortality, disability-adjusted life years and risk factors of cancer in Australia and comparison with OECD countries, 1990-2015: findings from the Global Burden of Disease Study 2015.
    Melaku YA; Appleton SL; Gill TK; Ogbo FA; Buckley E; Shi Z; Driscoll T; Adams R; Cowie BC; Fitzmaurice C
    Cancer Epidemiol; 2018 Feb; 52():43-54. PubMed ID: 29216565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    COVID-19 Excess Mortality Collaborators
    Lancet; 2022 Apr; 399(10334):1513-1536. PubMed ID: 35279232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.
    Lew JB; St John DJB; Xu XM; Greuter MJE; Caruana M; Cenin DR; He E; Saville M; Grogan P; Coupé VMH; Canfell K
    Lancet Public Health; 2017 Jul; 2(7):e331-e340. PubMed ID: 29253458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Colorectal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2019 Dec; 4(12):913-933. PubMed ID: 31648977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Cirrhosis Collaborators
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):245-266. PubMed ID: 31981519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nationwide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study.
    Olesen TB; Jensen H; Møller H; Jensen JW; Andersen B; Rasmussen M
    Elife; 2023 Jan; 12():. PubMed ID: 36695411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study.
    Lai AG; Pasea L; Banerjee A; Hall G; Denaxas S; Chang WH; Katsoulis M; Williams B; Pillay D; Noursadeghi M; Linch D; Hughes D; Forster MD; Turnbull C; Fitzpatrick NK; Boyd K; Foster GR; Enver T; Nafilyan V; Humberstone B; Neal RD; Cooper M; Jones M; Pritchard-Jones K; Sullivan R; Davie C; Lawler M; Hemingway H
    BMJ Open; 2020 Nov; 10(11):e043828. PubMed ID: 33203640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
    Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
    BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Report on health status of residents in areas with industrial, mining or military sites in Sardinia, Italy].
    Biggeri A; Lagazio C; Catelan D; Pirastu R; Casson F; Terracini B
    Epidemiol Prev; 2006; 30(1 Suppl 1):5-95. PubMed ID: 16826748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.
    Loveday C; Sud A; Jones ME; Broggio J; Scott S; Gronthound F; Torr B; Garrett A; Nicol DL; Jhanji S; Boyce SA; Williams M; Barry C; Riboli E; Kipps E; McFerran E; Muller DC; Lyratzopoulos G; Lawler M; Abulafi M; Houlston RS; Turnbull C
    Gut; 2021 Jun; 70(6):1053-1060. PubMed ID: 32855306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2017 Sep; 390(10100):1211-1259. PubMed ID: 28919117
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.